Age is a key factor in determining the efficiency of targeted therapy for Melanoma. Inhibition of BRAF oncogene is a targeted therapy approach to melanoma that is found to have less efficacy among older age.
from Medindia Health News https://ift.tt/3lrFK93
No comments:
Post a Comment